Try our Advanced Search for more refined results
Competition
Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.
Sign up for a 7-day FREE trial today!
Latest News in Competition
-
February 03, 2026
Upshot Of 'Skinny Label' Case May Go Beyond Pharma
The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," caries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.
-
February 03, 2026
5th Circ. Unsure Child Online Safety Law Tramples Speech
A Fifth Circuit panel appeared skeptical Tuesday of a tech media trade group's stance that a Mississippi internet safety law is unconstitutional, suggesting that the challenged statute may not implicate speech.
-
February 03, 2026
Tobacco Co. Says 'Time Bubble' Robbed It Of Fair TM Trial
BBK Tobacco & Foods LLP is asking an Arizona federal court for a new trial on its trademark infringement claims against Central Coast Agriculture Inc., saying the court wrongly created a "time bubble" that excluded all evidence from May 2021 on.
-
February 03, 2026
Novartis, Sandoz Face New Generic-Drug Price-Fixing Suit
Adding to sprawling antitrust litigation against pharmaceutical giants, 42 states and territories sued Novartis AG, Sandoz AG and other drug companies in Connecticut federal court on Monday, alleging that the companies colluded for years to fix prices and control markets for generic drugs.
-
February 03, 2026
4 Lessons From FTC's Successful Bid To Block Edwards Deal
The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.
Areas of Coverage
- AGENCIES
- U.S. Department of Justice, Antitrust Division
- Federal Trade Commission, Bureau of Competition
- European Commission, Competition Directorate
- UK Competition and Markets Authority
- Germany’s Federal Cartel Office
- China’s Ministry Of Commerce
- Japan Fair Trade Commission
- Korea Fair Trade Commission
- Canada’s Competition Bureau
- Brazil’s Council for Economic Defense
- POLICY & REGULATION
- Clayton Act
- Federal Trade Commission Act
- Foreign Corrupt Practices Act
- Racketeer Influenced and Corrupt Organizations Act
- Robinson-Patman Act
- Sherman Act
- International antitrust legislation and regulation
- ENFORCEMENT
- Criminal charges over antitrust issues
- Global cartel investigations and actions
- Merger reviews and second requests
- Merger challenges and divestiture orders
- Anti-monopoly actions
- Pharmaceutical pay-for-delay challenges
- Bid-rigging probes
- Kickback, bribery, and corruption cases
- Challenges to state aid and other subsidies
- LITIGATION
- Antitrust class actions
- Price-fixing cases
- Illegal monopoly suits
- PROFILES
- Personnel moves
- Profiles of competition practices
Readership
- Antitrust and competition lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals